Regulation of T cell development and activation by creatine kinase B

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Zhang, Yafeng ^a   Li, Hai ^a   Wang, Xiaoming ^a   Gao, Xiang ^b   Liu, Xiaolong ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CREATINE KINASE; CREATINE KINASE B; NUCLEAR RECEPTOR NUR77; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SELECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSGENE; ANIMAL; C57BL MOUSE; CELL LINEAGE; CYTOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; THYMUS; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; CELL LINEAGE; CREATINE KINASE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHORYLATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THYMUS GLAND; UP-REGULATION;

EID: 64249134657     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005000     Document Type: Article

References (50)

1. Goldrath AW, Bevan MJ (1999) Selecting and maintaining a diverse T-cell repertoire. Nature 402: 255-262.
2. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, et al. (1999) Selection of the T cell repertoire. Annu Rev Immunol 17: 829-874.
3. Hogquist KA, Baldwin TA, Jameson SC (2005) Central tolerance: learning self-control in the thymus. Nat Rev Immunol 5: 772-782.
4. Sprent J, Webb SR (1995) Intrathymic and extrathymic clonal deletion of T cells. Curr Opin Immunol 7: 196-205.
5. Starr TK, Jameson SC, Hogquist KA (2003) Positive and negative selection of T cells. Annu Rev Immunol 21: 139-176.
6. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, et al. (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29: 465-468.
7. Palmer E (2003) Negative selection - clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol 3: 383-391.
8. Sprent J, Kishimoto H (2002) The thymus and negative selection. Immunol Rev 185: 126-135.
9. Jameson SC (2002) Maintaining the norm: T-cell homeostasis. Nat Rev Immunol 2: 547-556.
10. Mustelin T, Taskén K (2003) Positive and negative regulation of T-cell activation through kinases and phosphatases. Biochem J 371: 15-27.
11. Qian D, Weiss A (1997) T cell antigen receptor signal transduction. Curr Opin Cell Biol 9: 205-212.
12. Owen MJ, Venkitaraman AR (1996) Signalling in lymphocyte development. Curr Opin Immunol 8: 191-198.
13. Rincon M (2001) MAP-kinase signaling pathways in T cells. Curr Opin Immunol 13: 339-345.
14. Cantrell D (1996) T cell antigen receptor signal transduction pathways. Annu Rev Immunol 14: 259-274.
15. Feske S (2007) Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 7: 690-702.
16. Koretzky GA, Myung PS (2001) Positive and negative regulation of T-cell activation by adaptor proteins. Nat Rev Immunol 1: 95-107.
17. Hubbard SR, Till JH (2000) Protein tyrosine kinase structure and function. Annu Rev Biochem 69: 373-398.
18. Cheng AM, Chan AC (1997) Protein tyrosine kinases in thymocyte development. Curr Opin Immunol 9: 528-533.
19. Knowles JR (1980) Enzyme-catalyzed phosphoryl transfer reactions. Annu Rev Biochem 49: 877-919.
20. Wyss M, Kaddurah-Daouk R (2000) Creatine and creatinine metabolism. Physiol Rev 80: 1107-1213.
21. Ames A (2000) CNS energy metabolism as related to function. Brain Res Rev 34: 42-68.
22. Tachikawa M, Fukaya M, Terasaki T, Ohtsuki S, Watanabe M (2004) Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur J Neurosci 20: 144-160.
23. Wallimann T, Dolder M, Schlattner U, Eder M, Hornemann T, et al. (1998) Creatine kinase: An enzyme with a central role in cellular energy metabolism. MAGMA 6: 116-119.
24. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM (1992) Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 281: 21-40.
25. Bürklen TS, Schlattner U, Homayouni R, Gough K, Rak M, et al. (2006) The creatine kinase/creatine connection to alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine deposits. J Biomed Biotechnol 2006: 1-11.
26. Balasubramani M, Day BW, Schoen RE, Getzenberg RH (2006) Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer. Cancer Res 66: 763-769.
27. Meffert G, Gellerich FN, Margreiter R, Wyss M (2005) Elevated creatine kinase activity in primary hepatocellular carcinoma. BMC Gastroenterol 5: 1-7.
28. Ishikawa J, Taniguchi T, Takeshita A, Maekawa M (2005) Increased creatine kinase BB activity and CKB mRNA expression in patients with hematologic disorders: Relation to methylation status of the CKB promoter. Clin Chim Acta 361: 135-140.
29. Huddleston HG, Wong KK, Welch WR, Berkowitz RS, Mok SC (2005) Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Gynecol Oncol 96: 77-83.
30. Sun G, Liu X, Mercado P, Jenkinson SR, Kypriotou M, et al. (2005) The zinc finger protein cKrox directs CD4 lineage differentiation during intrathymic T cell positive selection. Nat Immunol 6: 373-381.
31. van Deursen J, Heerschap A, Oerlemans F, Rultenbeek W, Jap P, et al. (1993) Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell 74: 621-631.
32. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ (1991) bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-888.
33. Amsen D, Calvo CR, Osborne BA, Kruisbeek AM (1999) Costimulatory signals are required for induction of transcription factor Nur77 during negative selection of CD4+CD8+ thymocytes. Proc Natl Acad Sci U S A 96: 622-627.
34. Bouillet P, Purton JF, Godfrey DI, Zhang L-C, Coultas L, et al. (2002) BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415: 922-926.
35. Punt JA, Osborne BA, Takahama Y, Sharrow SO, Singer A (1994) Negative selection of CD4+CD8+ thymocytes by T cell receptor-induced apoptosis requires a costimulatory signal that can be provided by CD28. J Exp Med 179: 709-713.
36. Williams LM, Rudensky AY (2007) Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 8: 277-284.
37. Mahajan VB, Pai KS, Lau A, Cunningham DD (2000) Creatine kinase, an ATP-generating enzyme, is required for thrombin receptor signaling to the cytoskeleton. Proc Natl Acad Sci U S A 22: 12062-12067.
38. Chang E-J, Ha J, Oerlemans F, Lee YJ, Lee SW, et al. (2008) Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nat Med 14: 966-972.
39. Kuiper JWP, Pluk H, Oerlemans F, van Leeuwen FN, de Lange F, et al. (2008) Creatine kinase-mediated ATP supply fuels actin-based evants in phagocytosis. PLoS Biol 6: e51.
40. Mulvaney PT, Stracke ML, Nam SW, Woodhouse E, O'Keefe M, et al. (1998) Cyclocreatine inhibits stimulated motility in tumor cells possessing creatine kinase. Int J Cancer 78: 46-52.
41. Shin J-B, Streijger F, Beynon A, Peters T, Gadzala L, et al. (2007) Hair bundles are specialized for ATP delivery via Creatine Kinase. Neuron 53: 371-386.
42. Debrincat MA, Zhang J-G, Willson TA, Silke J, Connolly LM, et al. (2007) Ankyrin repeat and suppressors of cytokine signaling box protein Asb-9 targets Creatine Kinase B for degradation. J Biol Chem 282: 4728-4737.
43. Ventura-Clapier R, Kuznetsov A, Veksler V, Boehm E, Anflous K (1998) Functional coupling of creatine kinases in muscles: species and tissue specificity. Mol Cell Biochem 184: 231-247.
44. Linette GP, Grusby MJ, Hedrick SM, Hansen TH, Glimcher LH, et al. (1994) Bcl-2 is upregulated at the CD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control Points. Immunity 1: 197-205.
45. + human thymocytes with high CXCR4-induced chemotaxis. Proc Natl Acad Sci U S A 102: 12867-12872.
46. + T cells. J Exp Med 197: 475-487.
47. Ohashi PS (2003) Negative selection and autoimmunity. Curr Opin Immunol 15: 668-676.
48. Liu X, Adams A, Wildt KF, Aronow B, Feigenbaum L, et al. (2003) Restricting Zap70 expression to CD4+CD8+ thymocytes reveals a T cell receptor-dependent proofreading mechanism controlling the completion of positive selection. J Exp Med 197: 363-373.
49. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, et al. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33: 401-406.
50. Ioannidis V, Beermann F, Clevers H, Held W (2001) The [beta]-catenin-TCF-1 pathway ensures CD4+CD8+ thymocyte survival. Nat Immunol 2: 691-697.